Advantage Investment Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$15K Buy
+200
New +$17.5K 0.01% 586
2015
Q3
Sell
-295
Closed -$12K 885
2015
Q2
$12K Buy
295
+32
+12% +$1.17K 0.01% 555
2015
Q1
$8K Buy
+263
New +$6.82K ﹤0.01% 632

Other funds holding RGEN

Advantage Investment Management's RGEN Position: Q3 2019 in Review

Advantage Investment Management opened a new position in Repligen (RGEN) in Q3 2019: 200 shares worth $15K. The stake represents 0.01% of the portfolio and ranks #586 among its holdings. This is a return to the name: Advantage Investment Management previously reported a position in RGEN as recently as Q2 2015.

Advantage Investment Management first reported a position in RGEN in Q1 2015 and has held it in 3 quarters since. 303 funds tracked by Wall St. Rank hold RGEN as of Q3 2019.

  • Advantage Investment Management held 200 shares of Repligen worth $15K as of Q3 2019.
  • Repligen was a new Advantage Investment Management position in Q3 2019.
  • Repligen made up 0.01% of Advantage Investment Management's portfolio in Q3 2019, its #586 holding.
  • Advantage Investment Management first reported a position in Repligen in Q1 2015 and has held it in 3 quarters since.
  • 303 funds tracked by Wall St. Rank held Repligen as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.